Citations (99)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Kamalesh K. Sankhala. (2017) Clinical development landscape in GIST: from novel agents that target accessory pathways to revisiting non-targeted therapies. Expert Opinion on Investigational Drugs 26:4, pages 427-443.
Read now
Read now
Molly M. Daughety & Michael C. Heinrich. (2016) Regorafenib for treatment of imatinib- and sunitinib-resistant metastatic gastrointestinal stromal tumors. Expert Opinion on Orphan Drugs 4:6, pages 659-670.
Read now
Read now
Lindsay C Overton & Michael C Heinrich. (2014)
Regorafenib for treatment of advanced gastrointestinal stromal tumors. Expert Opinion on Pharmacotherapy 15:4, pages 549-558.
Read now
Read now
I. M. Majer, H. Gelderblom, W. B. van den Hout, E. Gray & B. G. Verheggen. (2013) Cost-effectiveness of 3-year vs 1-year adjuvant therapy with imatinib in patients with high risk of gastrointestinal stromal tumour recurrence in the Netherlands; a modelling study alongside the SSGXVIII/AIO trial. Journal of Medical Economics 16:9, pages 1106-1119.
Read now
Read now
Klaus Kannengiesser, Reiner Mahlke, Frauke Petersen, Anja Peters, Matthias Ross, Torsten Kucharzik & Christian Maaser. (2012) Contrast-enhanced harmonic endoscopic ultrasound is able to discriminate benign submucosal lesions from gastrointestinal stromal tumors. Scandinavian Journal of Gastroenterology 47:12, pages 1515-1520.
Read now
Read now
Brian K Bednarski, Peter WT Pisters & Kelly K Hunt. (2012) The role of surgery in the multidisciplinary management of patients with localized gastrointestinal stromal tumors. Expert Review of Anticancer Therapy 12:8, pages 1069-1078.
Read now
Read now
Charles D. Blanke & Christopher L. Corless. (2005) State-of-the Art Therapy for Gastrointestinal Stromal Tumors. Cancer Investigation 23:3, pages 274-280.
Read now
Read now
Articles from other publishers (92)
Vinayak Venkataraman, Suzanne George & Gregory M Cote. (2023) Molecular Advances in the Treatment of Advanced Gastrointestinal Stromal Tumor. The Oncologist 28:8, pages 671-681.
Crossref
Crossref
Homma M. Khosroyani, Lillian R. Klug & Michael C. Heinrich. (2023) TKI Treatment Sequencing in Advanced Gastrointestinal Stromal Tumors. Drugs 83:1, pages 55-73.
Crossref
Crossref
Eleonora Turrini, Francesca Maffei & Carmela Fimognari. (2022) Effect of the Marine Polyketide Plocabulin on Tumor Progression. Marine Drugs 21:1, pages 38.
Crossref
Crossref
Lemi Türker. (2022) Some Tautomers of Dacarbazine - A DFT Study. Earthline Journal of Chemical Sciences, pages 47-62.
Crossref
Crossref
Charlotte Margareta Brinch, Ninna Aggerholm-Pedersen, Estrid Hogdall & Anders Krarup-Hansen. (2022) Medical oncological treatment for patients with Gastrointestinal Stromal Tumor (GIST) – A systematic review. Critical Reviews in Oncology/Hematology 172, pages 103650.
Crossref
Crossref
Annick D. Van den Abbeele, Christopher G. Sakellis & Suzanne George. 2022. Nuclear Medicine and Molecular Imaging. Nuclear Medicine and Molecular Imaging
238
251
.
Christopher G. Sakellis, Heather A. Jacene & Annick D. Van den Abbeele. 2020. Nuclear Oncology. Nuclear Oncology
1
19
.
Christopher G. Sakellis, Heather A. Jacene & Annick D. Van den Abbeele. 2022. Nuclear Oncology. Nuclear Oncology
847
864
.
Bayan Al-Share, Abdulrahman Alloghbi, Mohammed Najeeb Al Hallak, Hafiz Uddin, Asfar Azmi, Ramzi M. Mohammad, Steve H Kim, Anthony F. Shields & Philip A Philip. (2021) Gastrointestinal stromal tumor: a review of current and emerging therapies. Cancer and Metastasis Reviews 40:2, pages 625-641.
Crossref
Crossref
Yannick Wang, Agnieszka Wozniak, Jasmien Wellens, Yemarshet K. Gebreyohannes, Maria Jose Guillén, Pablo M. Avilés, Maria Debiec-Rychter, Raf Sciot & Patrick Schöffski. (2020) Plocabulin, a novel tubulin inhibitor, has potent antitumor activity in patient-derived xenograft models of gastrointestinal stromal tumors. Translational Oncology 13:11, pages 100832.
Crossref
Crossref
Germán Calderillo, Matías Muñoz-Medel, Edelmira Carbajal, Miguel Córdova-Delgado, Doris Durán, Ignacio N. Retamal, Piga Fernández, Absalón Espinoza, Rodrigo Salas, María de la Paz Mastretta, Héctor Galindo, Bruno Nervi, Jorge Madrid, Cesar Sánchez, Carolina Ibáñez, José Peña, Sebastián Mondaca, Francisco Acevedo, Erica Koch, Mauricio P. Pinto & Marcelo Garrido. (2020) Retrospective Analysis of Chilean and Mexican GI Stromal Tumor Registries: A Tale of Two Latin American Realities. JCO Global Oncology:6, pages 647-657.
Crossref
Crossref
Gautam Shubhankar, Rajdeep Singh, Manu Vats, AbhilashD Reddy & NaveenKumar Solanki. (2020) Current Management of Gastrointestinal Stromal Tumor. MAMC Journal of Medical Sciences 6:1, pages 1.
Crossref
Crossref
John Nemunaitis, Sebastian Bauer, Jean-Yves Blay, Khalil Choucair, Hans Gelderblom, Suzanne George, Patrick Schöffski, Margaret von Mehren, John Zalcberg, Haroun Achour, Rodrigo Ruiz-Soto & Michael C Heinrich. (2020) Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib. Future Oncology 16:1, pages 4251-4264.
Crossref
Crossref
Lillian R. Klug, Amber E. Bannon, Nathalie Javidi-Sharifi, Ajia Town, William H. Fleming, Judy K. VanSlyke, Linda S. Musil, Jonathan A. Fletcher, Jeffrey W. Tyner & Michael C. Heinrich. (2018) LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma. Oncogene 38:8, pages 1200-1210.
Crossref
Crossref
Attila Kollár, Pedro Nazareth Aguiar, Nora Manoukian Forones & Ramon Andrade De Mello. 2019. International Manual of Oncology Practice. International Manual of Oncology Practice
817
849
.
Fei Xu, Xiaohong Ma, Yichen Wang, Yuan Tian, Wei Tang, Meng Wang, Ren Wei & Xinming Zhao. (2018) CT texture analysis can be a potential tool to differentiate gastrointestinal stromal tumors without KIT exon 11 mutation. European Journal of Radiology 107, pages 90-97.
Crossref
Crossref
Margaret von MehrenHeikki Joensuu. (2018) Gastrointestinal Stromal Tumors. Journal of Clinical Oncology 36:2, pages 136-143.
Crossref
Crossref
Xingye Wu, Juan Li, Yi Zhou, Yun Mao, Shiqiao Luo, Xuemei He, Li Wang, Yifan Shen, Hua Zhang, Longwei Yang & Jun Zhang. (2018) Relative Factors Analysis of Imatinib Trough Concentration in Chinese Patients with Gastrointestinal Stromal Tumor. Chemotherapy 63:6, pages 301-307.
Crossref
Crossref
Michael G. Porter & Scott M. Stoeger. (2017) Atypical Colorectal Neoplasms. Surgical Clinics of North America 97:3, pages 641-656.
Crossref
Crossref
Margaret von Mehren, Brian P. Rubin, Douglas B. Flieder & Chandrajit P. Raut. 2017. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer
470
492
.
Gabriel Tinoco, Guozhi Hu, Ana Paz-Mej?a & Jonathan Trent. 2017. Gastrointestinal Stromal Tumors. Gastrointestinal Stromal Tumors
171
185
.
Christian F. Meyer. 2017. Gastrointestinal Stromal Tumors. Gastrointestinal Stromal Tumors
157
170
.
Christopher G. Sakellis, Heather A. Jacene & Annick D. Van den Abbeele. 2017. Nuclear Oncology. Nuclear Oncology
709
723
.
Vivek Subbiah, Kenneth R. Hess, Muhammad Rizwan Khawaja, Michael J. Wagner, Chad Tang, Aung Naing, Siqing Fu, Filip Janku, Sarina Piha-Paul, Apostolia M. Tsimberidou, Cynthia E. Herzog, Joseph A. Ludwig, Shreyaskumar Patel, Vinod Ravi, Robert S. Benjamin, Funda Meric-Bernstam & David S. Hong. (2016) Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies. Scientific Reports 6:1.
Crossref
Crossref
Gustavo Schvartsman, Michael J. Wagner, Chrystia M. Zobniw, Van Anh Trinh, Shreyaskumar Patel & Neeta Somaiah. (2016) An Unusual Case of Central Retinal Vein Occlusion and Review of the Toxicity Profile of Regorafenib in GIST Patients. Current Oncology Reports 18:8.
Crossref
Crossref
Yannis Metaxas, Georgios Oikonomopoulos & George Pentheroudakis. (2016) Update on clinical research and state of the art management of patients with advanced sarcomas and GIST. ESMO Open 1:3, pages e000065.
Crossref
Crossref
Christopher G. Sakellis, Heather A. Jacene & Annick D. Van den Abbeele. 2016. Nuclear Oncology. Nuclear Oncology
1
15
.
Dimitra G. Theodoropoulos. (2015) Gastrointestinal stromal tumors of the colon and rectum. Seminars in Colon and Rectal Surgery 26:2, pages 84-90.
Crossref
Crossref
Benjamin Garlipp & Christiane J. Bruns. (2015) State of the Art in the Treatment of Gastrointestinal Stromal Tumors. Gastrointestinal Tumors 1:4, pages 221-236.
Crossref
Crossref
Attila Kollàr. 2015. International Manual of Oncology Practice. International Manual of Oncology Practice
691
717
.
Attila Kollàr, Marco Maruzzo, Christina Messiou, Elisabeth Cartwright, Aisha Miah, Juan Martin-Liberal, Khin Thway, Ellen McGrath, Alison Dunlop, Komel Khabra, Beatrice Seddon, Palma Dileo, Mark Linch, Ian Judson & Charlotte Benson. (2014) Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program. Clinical Sarcoma Research 4:1.
Crossref
Crossref
MARISTELLA SAPONARA, CRISTIAN LOLLI, MARGHERITA NANNINI, VALERIO DI SCIOSCIO, CARLA SERRA, ANNA MANDRIOLI, MARIA CATERINA PALLOTTI, GUIDO BIASCO & MARIA ABBONDANZA PANTALEO. (2014) Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours. Oncology Letters 8:4, pages 1793-1799.
Crossref
Crossref
Maristella Saponara, Maria Abbondanza Pantaleo, Margherita Nannini & Guido Biasco. (2014) Treatments for gastrointestinal stromal tumors that are resistant to standard therapies. Future Oncology 10:13, pages 2045-2059.
Crossref
Crossref
Danielle Ferraro & John Zalcberg. (2014) Regorafenib in gastrointestinal stromal tumors: clinical evidence and place in therapy. Therapeutic Advances in Medical Oncology 6:5, pages 222-228.
Crossref
Crossref
Jay Patrick Lopez, Csaba Gajdos & Anthony Elias. (2014) Trabectedin: Novel Insights in the Treatment of Advanced Sarcoma. Current Oncology Reports 16:6.
Crossref
Crossref
Joaquina Baranda, Rashna Madan & Andrew Godwin. 2013. Handbook of Therapeutic Biomarkers in Cancer. Handbook of Therapeutic Biomarkers in Cancer
267
311
.
George D Demetri, Peter Reichardt, Yoon-Koo Kang, Jean-Yves Blay, Piotr Rutkowski, Hans Gelderblom, Peter Hohenberger, Michael Leahy, Margaret von Mehren, Heikki Joensuu, Giuseppe Badalamenti, Martin Blackstein, Axel Le Cesne, Patrick Sch?ffski, Robert G Maki, Sebastian Bauer, Binh Bui Nguyen, Jianming Xu, Toshirou Nishida, John Chung, Christian Kappeler, Iris Kuss, Dirk Laurent & Paolo G Casali. (2013) Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial. The Lancet 381:9863, pages 295-302.
Crossref
Crossref
Burton L. Eisenberg & J. Marc Pipas. (2012) Gastrointestinal Stromal Tumor?Background, Pathology, Treatment. Hematology/Oncology Clinics of North America 26:6, pages 1239-1259.
Crossref
Crossref
Maristella Saponara, Maria Abbondanza Pantaleo, Margherita Nannini & Guido Biasco. (2012) Chronic therapy in gastrointestinal stromal tumours (GISTs): the big gap between theory and practice. Targeted Oncology 7:4, pages 243-246.
Crossref
Crossref
S G Holtan, S R Palmer, S H Okuno & W J Hogan. (2012) Graft vs GIST?. Bone Marrow Transplantation 47:9, pages 1246-1247.
Crossref
Crossref
Zubin M. Bamboat & Ronald P. DeMatteo. (2012) Updates on the Management of Gastrointestinal Stromal Tumors. Surgical Oncology Clinics of North America 21:2, pages 301-316.
Crossref
Crossref
Shilpa Grover, Stanley W. Ashley & Chandrajit P. Raut. (2012) Small intestine gastrointestinal stromal tumors. Current Opinion in Gastroenterology 28:2, pages 113-123.
Crossref
Crossref
Margaret von Mehren, Douglas B. Flieder & Chandrajit P. Raut. 2012. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer
465
483
.
Stanley Bruce Malkowicz. 2012. Campbell-Walsh Urology. Campbell-Walsh Urology
1506
1515.e3
.
Megan V. Caram & Scott M. Schuetze. (2011) Advanced or metastatic gastrointestinal stromal tumors: Systemic treatment options. Journal of Surgical Oncology 104:8, pages 888-895.
Crossref
Crossref
Jean-François Morère, Françoise Mornex & Denis SoulièresP. A. Cassier, P. Méeus, J.-Y. Scoazec & J. Y. Blay. 2011. Thérapeutique du cancer. Thérapeutique du cancer
305
325
.
Peter Hohenberger & Burton Eisenberg. (2010) Role of Surgery Combined with Kinase Inhibition in the Management of Gastrointestinal Stromal Tumor (GIST). Annals of Surgical Oncology 17:10, pages 2585-2600.
Crossref
Crossref
M. Eriksson. (2010) Histology-driven chemotherapy of soft-tissue sarcoma. Annals of Oncology 21, pages vii270-vii276.
Crossref
Crossref
Yoichi Kobayashi, Akiko Tozawa, Yoshiaki Okuma, Kazushige Kiguchi & Bunpei Ishizuka. (2010) Complete remission with intraperitoneal cisplatin followed by prolonged oral etoposide in a stage IIIc primary leiomyosarcoma of the fallopian tube patient. Journal of Obstetrics and Gynaecology Research 36:4, pages 894-897.
Crossref
Crossref
Bernadette Liegl-Atzwanger, Jonathan A. Fletcher & Christopher D. M. Fletcher. (2010) Gastrointestinal stromal tumors. Virchows Archiv 456:2, pages 111-127.
Crossref
Crossref
Peter A. Learn, Jason K. Sicklick & Ronald P. DeMatteo. (2010) Randomized Clinical Trials in Gastrointestinal Stromal Tumors. Surgical Oncology Clinics of North America 19:1, pages 101-113.
Crossref
Crossref
William Pao & Nicolas Girard. 2010. Handbook of Cell Signaling. Handbook of Cell Signaling
615
631
.
Daniel J. Renouf, Lora Wilson & Charles D. Blanke. (2009) Successes and Challenges in Translational Research: The Development of Targeted Therapy for Gastrointestinal Stromal Tumours. Clinical Cancer Research 15:12, pages 3908-3911.
Crossref
Crossref
Lúcio Roberto de Oliveira das Neves, Celina Tizuko Fujiyama Oshima, Ricardo Artigiani-Neto, Gianni Yanaguibashi, Laércio Gomes Lourenço & Nora Manoukian Forones. (2009) Ki67 and p53 in gastrointestinal stromal tumors - GIST. Arquivos de Gastroenterologia 46:2, pages 116-120.
Crossref
Crossref
T. Peter Kingham & Ronald P. DeMatteo. (2009) Multidisciplinary Treatment of Gastrointestinal Stromal Tumors. Surgical Clinics of North America 89:1, pages 217-233.
Crossref
Crossref
Bernadette Liegl, Jason L. Hornick & Alexander J.F. Lazar. (2009) Contemporary Pathology of Gastrointestinal Stromal Tumors. Hematology/Oncology Clinics of North America 23:1, pages 49-68.
Crossref
Crossref
Richard Quek & Suzanne George. (2009) Gastrointestinal Stromal Tumor: A Clinical Overview. Hematology/Oncology Clinics of North America 23:1, pages 69-78.
Crossref
Crossref
Chandrajit P. Raut, Jason L. Hornick & Monica M. Bertagnolli. 2009. The Biology of Gastric Cancers. The Biology of Gastric Cancers
135
163
.
Vincent H Mabasa, Suzanne CM Taylor, Christina CY Chu, Veronika Moravan, Karissa Johnston, Stuart Peacock & Meg Knowling. (2008) Verification of imatinib cost-effectiveness in advanced gastrointestinal stromal tumor in British Columbia (VINCE-BC study). Journal of Oncology Pharmacy Practice 14:3, pages 105-112.
Crossref
Crossref
Sun Jin Sym, Min‐Hee Ryu, Jae‐Lyun Lee, Heung Moon Chang, Tae‐Won Kim, Hee Cheol Kim, Ki Hun Kim, Jeong Hwan Yook, Byung Sik Kim & Yoon‐Koo Kang. (2008) Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs). Journal of Surgical Oncology 98:1, pages 27-33.
Crossref
Crossref
Annick D. Van den Abbeele & Mehmet Ertuk. (2008) FDG-PET to Measure Response to Targeted Therapy: The Example of Gastrointestinal Stromal Tumor and Imatinib Mesylate (Gleevec). PET Clinics 3:1, pages 77-87.
Crossref
Crossref
George D. Demetri & Heikki Joensuu. (2008) Systemic treatment of patients with gastrointestinal stromal tumor: Current status and future opportunities. European Journal of Cancer Supplements 6:1, pages 1-14.
Crossref
Crossref
Alessandro Fichera, Ronald P. DeMatteo & Fabrizio Michelassi. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
1465
1475
.
Jennifer Wheler & Razelle Kurzrock. 2008. Targeted Cancer Therapy. Targeted Cancer Therapy
1
19
.
Juan C. Gutierrez, Luiz O. Pita De Oliveira, Eduardo A. Perez, Caio Rocha-Lima, Alan S. Livingstone & Leonidas G. Koniaris. (2007) Optimizing Diagnosis, Staging, and Management of Gastrointestinal Stromal Tumors. Journal of the American College of Surgeons 205:3, pages 479-491.
Crossref
Crossref
Sofia Pérez-Gutiérrez, Ricardo González-Cámpora, Joaquín Amérigo-Navarro, Antonio Beato-Moreno, Maria Sánchez-León, María Jesús Pareja Megía, Juan Antonio Virizuela-Echaburu & Antonio López-Beltrán. (2007) Expression of P-glycoprotein and metallothionein in gastrointestinal stromal tumor and leiomyosarcomas. Clinical implications. Pathology & Oncology Research 13:3, pages 203-208.
Crossref
Crossref
Philip J. Saylor & Tony R. Reid. (2007) Tumor Lysis Syndrome After Treatment of a Gastrointestinal Stromal Tumor With the Oral Tyrosine Kinase Inhibitor Sunitinib. Journal of Clinical Oncology 25:23, pages 3544-3546.
Crossref
Crossref
Eugene A. Choi & Barry W. Feig. (2007) Surgical resection in metastatic gastrointestinal stromal tumors. Current Oncology Reports 9:4, pages 303-308.
Crossref
Crossref
Y You & Ronald DeMatteo. 2007. Gastrointestinal Oncology. Gastrointestinal Oncology
337
350
.
S. Bauer & J. Schütte. 2007. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie
692
712
.
Ian D. Schnadig & Charles D. Blanke. (2006) Gastrointestinal stromal tumors: Imatinib and beyond. Current Treatment Options in Oncology 7:6, pages 427-437.
Crossref
Crossref
George D Demetri, Allan T van Oosterom, Christopher R Garrett, Martin E Blackstein, Manisha H Shah, Jaap Verweij, Grant McArthur, Ian R Judson, Michael C Heinrich, Jeffrey A Morgan, Jayesh Desai, Christopher D Fletcher, Suzanne George, Carlo L Bello, Xin Huang, Charles M Baum & Paolo G Casali. (2006) Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. The Lancet 368:9544, pages 1329-1338.
Crossref
Crossref
M. L. Harrison & D. Goldstein. (2006) Management of metastatic gastrointestinal stromal tumour in the Glivec era: a practical case-based approach. Internal Medicine Journal 36:6, pages 367-377.
Crossref
Crossref
Margaret von Mehren. (2006) Imatinib-refractory gastrointestinal stromal tumors: The clinical problem and therapeutic strategies. Current Oncology Reports 8:3, pages 192-197.
Crossref
Crossref
P. Reichardt, P. Hohenberger & U. Schneider. 2006. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie
3999
4013
.
Nathalie Théou, Sophie Gil, Anne Devocelle, Catherine Julié, Anne Lavergne-Slove, Alain Beauchet, Patrice Callard, Robert Farinotti, Axel Le Cesne, Antoinette Lemoine, Laurence Faivre-Bonhomme & Jean-François Emile. (2005) Multidrug Resistance Proteins in Gastrointestinal Stromal Tumors: Site-Dependent Expression and Initial Response to Imatinib. Clinical Cancer Research 11:21, pages 7593-7598.
Crossref
Crossref
Harry J. LongIIIIII, John A. Blessing & Joel Sorosky. (2005) Phase II trial of dacarbazine, mitomycin, doxorubicin, and cisplatin with sargramostim in uterine leiomyosarcoma: A Gynecologic Oncology Group study. Gynecologic Oncology 99:2, pages 339-342.
Crossref
Crossref
Xavier Garcia del Muro, Antonio Lopez-Pousa, Javier Martin, Jose M. Buesa, Javier Martinez-Trufero, Antonio Casado, Andres Poveda, Josefina Cruz, Isabel Bover & Joan Maurel. (2005) A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma. Cancer 104:8, pages 1706-1712.
Crossref
Crossref
Margaret von Mehren & James C. Watson. (2005) Gastrointestinal Stromal Tumors. Hematology/Oncology Clinics of North America 19:3, pages 547-564.
Crossref
Crossref
Bohuslav MELICHAR, Zbynek VOBORIL, Jan NOZICKA, Ales RYSKA, Hana URMINSKÁ, Tomás VANECEK & Michal MICHAL. (2005) Pathological Complete Response in Advanced Gastrointestinal Stromal Tumor after Imatinib Therapy. Internal Medicine 44:11, pages 1163-1168.
Crossref
Crossref
Bohuslav Melichar, Zbyněk Vobořil, Jan Nožička, Jaroslav CermanJrJr, Karolina Melicharová, Jindřiška Mergancová, Stanislav Filip, Antonín Krajina, René Vobořil & Pavel Jandík. (2019) Hepatic Arterial Infusion Chemotherapy in Sarcoma Liver Metastases: A Report of 6 Cases. Tumori Journal 91:1, pages 19-23.
Crossref
Crossref
Michelle Scurr & Ian Judson. 2005.
591
604
.
Bruno Landi, Thierry Lecomte, Anne Berger & Christophe Cellier. (2004) Traitement des tumeurs stromales digestives. Gastroent?rologie Clinique et Biologique 28:10, pages 893-901.
Crossref
Crossref
Monica S. Cypriano, Jesse J. Jenkins, Alberto S. Pappo, Bhaskar N. Rao & Najat C. Daw. (2004) Pediatric gastrointestinal stromal tumors and leiomyosarcoma. Cancer 101:1, pages 39-50.
Crossref
Crossref
Haralabos P. Kalofonos, Dimitrios Bafaloukos, Theodoros G. Kourelis, Michalis V. Karamouzis, Panagiotis Megas, Grigorios Iconomou, Ekaterini Tsiata, Dimitrios Dimitropoulos, Paris Kosmidis & E Lampiris. (2004) Adriamycin and Cis-Platinum as First-Line Treatment in Unresectable Locally Advanced or Metastatic Adult Soft-Tissue Sarcomas. American Journal of Clinical Oncology 27:3, pages 307-311.
Crossref
Crossref
Michael Fanucchi. (2004) Update on the management of connective tissue malignancies. Seminars in Oncology 31, pages 16-19.
Crossref
Crossref
Robert G. Maki. (2004) Gastrointestinal stromal tumors respond to tyrosine kinase-targeted therapy. Current Treatment Options in Gastroenterology 7:1, pages 13-17.
Crossref
Crossref
Eric J. Lowe, Jesse J. Jenkins, Fredric A. Hoffer, Thom E. Lobe & Victor M. Santana. (2003) Anemia and a large abdominal tumor in an adolescent. Pediatric Blood & Cancer 42:2, pages 200-204.
Crossref
Crossref
Hayley S. Ramshaw, Timothy R. Hercus, Ian N. Olver & Angel F. Lopez. 2004. Hematopoietic Growth Factors in Oncology. Hematopoietic Growth Factors in Oncology
447
465
.
Margaret von Mehren. (2003) Recent advances in the management of gastrointestinal stromal tumors. Current Oncology Reports 5:4, pages 288-294.
Crossref
Crossref
R Komdeur, B.E.C Plaat, W.T.A van der Graaf, H.J Hoekstra, H Hollema, E van den Berg, N Zwart, R.J Scheper & W.M Molenaar. (2003) Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade. European Journal of Cancer 39:7, pages 909-916.
Crossref
Crossref
John H. Edmonson, John A. Blessing, Jonathan A. Cosin, David Scott Miller, David E. Cohn & Jacob Rotmensch. (2002) Phase II Study of Mitomycin, Doxorubicin, and Cisplatin in the Treatment of Advanced Uterine Leiomyosarcoma: A Gynecologic Oncology Group Study. Gynecologic Oncology 85:3, pages 507-510.
Crossref
Crossref